Showing results (1201-1210 of 1,520) with videos related to

Sort By:
Pageof 152
Journal of Clinical Immunology|August 8, 2016
Thoracic Surgery in Chronic Granulomatous Disease: a 25-Year Single-Institution ExperiencePaul L Feingold, Humair S Quadri, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancerNicole J McCarthy, Xiaowei Yang, Ilona R Linnoila, et al.
Digestive Diseases and Sciences|October 15, 2022
Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical OutcomesNathaniel A Cohen, Joshua M Steinberg, Alexa Silfen, et al.
Plos One|March 31, 2009
A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesisCourtney A Granville, Regan M Memmott, Andria Balogh, et al.
Bone Marrow Transplantation|July 20, 2023
Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host diseaseDavid Beshensky, Filip Pirsl, Noa G Holtzman, et al.
Cell Death & Disease|July 25, 2012
Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumorsI Petrini, P S Meltzer, P A Zucali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawalN Dawson, W D Figg, O W Brawley, et al.
Nature Communications|October 28, 2025
Tumor-targeted top1 inhibitor delivery with optimized parp inhibition in advanced solid tumors: a phase i trial of gapped schedulingAnish Thomas, Nobuyuki Takahashi, Lenka Oplustil O'Connor, et al.
Cancer Immunology Research|April 30, 2014
Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancerJames L Gulley, Ravi A Madan, Kwong Y Tsang, et al.
Gynecologic Oncology|August 5, 2020
Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatmentJung-Min Lee, Christina M Annunziata, John L Hays, et al.
Pageof 152